ストックスクリーナーアプリを入手
20.06
8.82%
-1.94
アフターアワーズ：
20.30
0.24
+1.20%
前日終値:
$22.00
開ける：
$21.95
24時間の取引高:
260.18K
Relative Volume:
2.26
時価総額：
$1.39B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.87%
1か月 パフォーマンス:
-17.35%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$19.87
$22.50
1週間の範囲:
$19.87
$22.50
52週間の値動き範囲:
$19.87
$27.20
Alamar Biosciences Inc Stock (ALMR) Company Profile
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
20.06 | 1.52B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc (ALMR) 最新ニュース
Number of shareholders of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) Net Income (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Liabilities - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash Equivalents (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Enterprise Value - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Financing (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Equity (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Return On Assets (TTM) - Zacks Investment Research
This Southwest Gas Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
A Quick Look at Today's Ratings for Alamar Biosciences(ALMR.US), With a Forecast Between $27 to $35 - Moomoo
Stifel Initiates Alamar Biosciences at Buy With $28 Price Target - marketscreener.com
Leerink Initiates Alamar Biosciences at Outperform With $35 Price Target - marketscreener.com
Alamar Biosciences, Inc. (ALMR) Market Cap - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (TTM) - Zacks Investment Research
Stifel initiates Alamar Biosciences stock with buy rating - Investing.com UK
JPMorgan initiates Alamar Biosciences stock with overweight rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Alamar Biosciences stock with overweight rating - Investing.com India
Stifel initiates Alamar Biosciences stock with buy rating By Investing.com - Investing.com India
Alamar Biosciences, Inc. (ALMR) Gross Margin (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Assets (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Total Long Term Debt (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Dividend Yield (TTM) - Zacks Investment Research
Alamar Biosciences Revenue Jump And IPO Spotlight Neuro Focus Potential - Sahm
Alamar Biosciences, Inc. (ALMR) Ps Ratio (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Revenue (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Net Income (TTM) - Zacks Investment Research
ALMR: Alamar Biosciences, Inc.Price & Consenus Chart - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Free Cash Flow (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Profit Margin (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Price To Cash Flow - Zacks Investment Research
Alamar Biosciences Q1 Loss Widens, Revenue Rises - Moomoo
Alamar Biosciences 1Q Rev $26M >ALMR - Moomoo
Alamar Biosciences, Inc. 1Q 2026: Revenue $26.04M, EPS $(1.74) — 10-Q Summary - TradingView
ALMR SEC FilingsAlamar Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Alamar Biosciences Reports First Quarter 2026 Financial Results - The Manila Times
Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share - marketscreener.com
Alamar Biosciences (Nasdaq: ALMR) posts 99% Q1 2026 revenue growth - Stock Titan
Earnings Flash (ALMR) Alamar Biosciences, Inc. Reports Q1 Revenue $26.0M - marketscreener.com
Fresh off a $220M IPO, Alamar expands neuro tests and posts $26M quarter - Stock Titan
Alamar Biosciences (ALMR) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
ALMR Technical Analysis & Stock Price Forecast - Intellectia AI
Proteomics firm Alamar climbs 40% after upsized IPO - MSN
Investors can watch Alamar's BofA Healthcare Conference webcast May 12 - Stock Titan
Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference - GlobeNewswire
Alamar Biosciences to present at BofA Securities 2026 Healthcare Conference on May 12 - Pluang
Alamar Biosciences Inc - Reuters
Alamar Biosciences Index Debut And Shelf Filing Reshape Investor Tradeoffs - Sahm
Alamar Biosciences Inc (ALMR) 財務データ
Alamar Biosciences Inc (ALMR) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.22%
1.41%
大文字化:
|
ボリューム (24 時間):